Protagenic Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:PTIX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
12 Oct 23	BuyUS$6,480	Alexander Arrow	Individual		8,000	US$0.81

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.6%.

Top 15 shareholders own 29.79% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.6%	Garo Armen	734,322	US$917.9k	-1.19%	no data
5.41%	Armistice Capital LLC	240,000	US$300.0k	0%	0.01%
3.4%	Khalil Barrage	150,880	US$188.6k	47.2%	no data
1.03%	Alexander Arrow	45,815	US$57.3k	21.2%	no data
0.84%	David Lovejoy	37,200	US$46.5k	0%	no data
0.75%	The Vanguard Group, Inc.	33,166	US$41.5k	0.65%	no data
0.57%	Geode Capital Management, LLC	25,199	US$31.5k	0%	no data
0.42%	FNY Investment Advisers, LLC	18,750	US$23.4k	0%	0.03%
0.31%	State Street Global Advisors, Inc.	13,812	US$17.3k	0%	no data
0.3%	Susquehanna International Group, LLP, Asset Management Arm	13,197	US$16.5k	0%	no data
0.2%	Tower Research Capital LLC	9,026	US$11.3k	59.7%	no data
0.00059%	Wells Fargo & Company, Private Banking and Investment Banking Arm	26	US$32.7	4%	no data
0.00002%	Bank of America Corporation, Asset Management Arm	1	US$1.1	0%	no data
0.00002%	Carson Wealth Management Group	1	US$1.1	0%	no data
0.00002%	Morgan Stanley, Investment Banking and Brokerage Investments	1	US$1.1	0%	no data